Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-08-27

Clinical Trial Update: Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Pilot study evaluating safety and efficacy of sulfasalazine in pulmonary arterial hypertension across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: RenJi Hospital | Conditions: Pulmonary Arterial Hypertension | Phase 1, Phase 2 | Status: UNKNOWN